Abstract. Renal morphological parameters were determined in rats intratracheally instilled with model cadmium-containing silica nanoparticles (Cd-SiNPs, 1mg/rat), also exploring whether their potential modifications would be associated with toxicogenomic changes. CdSiNP effects, evaluated 7 and 30 days post-exposure, were assessed by (i) histopathology (Haematoxylin/Eosin Staining), (ii) characterization of apoptotic features by TUNEL staining. Data were compared with those obtained by CdCl 2 (400µg/rat), SiNPs (600µg/rat), 0.1 ml saline. Area-specific cell apoptosis was observed in all treatment groups: cortex and inner medulla were the most affected regions. Apoptotic changes were apparent at 7 days postexposure in both areas, and were still observable in inner medulla 30 days after treatment. Increase in apoptotic frequency was more pronounced in Cd-SiNP-treated animals compared to either CdCl 2 or SiNPs. Histological findings showed comparable alterations in the renal glomerular (cortex) architecture occurring in all treatment groups at both time-points considered. The glomeruli appeared often collapsed, showing condensed, packed mesangial and endothelial cells. Oedematous haemorrhagic glomeruli were also observed in Cd-SiNPstreated animals. Bare SiNPs caused morphological and apoptotic changes without modifying the renal gene expression profile. These findings support the concept that multiple assays and an integrated testing strategy should be recommended to characterize toxicological responses to nanoparticles in mammalian systems.
Morphological and cytohistochemical evaluation of renal effects of cadmium-doped silica nanoparticles given intratracheally to rat.
Introduction
A variety of nanomaterials have been studied and utilized in widespread biological applications [1] . Among them, silica/cadmium containing nanomaterials have attracted much attention in the latest years for their applications in medicine and industrial manufacturing, synthesis and engineering [2, 3, 4] .
Information on toxicological and health impact of these nanomaterials is still limited although occupational respiratory exposure to cadmium (Cd) nanoparticles may occur in many sectors, including manufacturing, research laboratories and work sites in industry.
Most of the studies on the biological effects of nanoparticles are often focused on pulmonary toxicity being the lungs the first port of entry by inhalation and the tissue in which the nanoparticles can easily disperse due to their very low density. Following the process of translocation across biological barriers, nano-SiO 2 (silica) can be transported into the blood and deposit in target organs where the nanoparticles can exert potential toxic effects [5] . Kidney could be a target because of its role in elimination of xenobiotics. Specifically to nano-SiO 2 , it has been reported that these nanoparticle exhibit prominent distribution in several tissues including kidney after intravenous injection in mice [6] . In rats, Cho et al. [7] demonstrated that, after absorption, silica nanoparticles are efficiently internalized in renal cells and rapidly excreted in urine. Recently, cadmium nanoparticles have been shown to deposit in rats kidney after intraperitoneal injection [8] and both free cadmium and nanoparticles accumulated and increased with doses in this tissue [8] .
Cd has well-established pneumotoxicity and nephrotoxicity as documented by epidemiological studies and reports in workers chronically exposed by inhalation [9, 10] . Experiments using animal models indicated that translocation of pulmonary cadmium to the kidney occurs readily for inhalation of cadmium chloride [see review 11] .
Our recent studies on model cadmium-containing silica nanoparticles (Cd-SiNPs) indicated longlasting gene expression changes occurring in kidney after intratracheal instillation (i.t.) of these nanoparticles in rats [12] . Compared with CdCl 2 the effect of Cd-SiNPs was more selective. Delayed gene expression alterations linked to apoptosis and regulatory processes were observed 30 days posttreatment in rats given Cd-SiNPs but not in those receiving CdCl 2 . In this work, cyto-histochemical methods were used to examine renal responses in rats after i.t. application of Cd-SiNPs as well as to determine whether morphological and biochemical parameters were modified by these nanoparticles in association with toxicogenomic changes. The effect of CdSiNPs was evaluated at 7 and 30 days post-exposure in comparison with that caused by administration of equivalent amount of CdCl 2 or SiNPs.
Materials and Methods

Nanoparticles
The method used to produce Cd-SiNPs was previously described [13] . The particles presented amorphous and crystalline structure (confirmed by X-ray diffraction analysis), spherical form, primary particle size range of 20-80 nm and specific surface area of about 200 m 2 /g. Dynamic light scattering (DLS) determination of the Cd-SiNPs size distribution showed tendency to form aggregates and agglomerates of about 350 nm, and a zeta potential of -23 mV (in deionized water). Flame-atomic absorption analysis was used to determine metal impurities and the release of cadmium from nanoparticles dispersed in physiological solution. Maximum cadmium release was 15% after 16 hr. Further metal release was negligible in the subsequent 10-day period. Main impurities were Ca (0.3%), Na (0.2%), K (0.2%), Fe (0.04%) and Mn (0.001%). Other metals were present in quantities less than 1 ‰. Cadmium and silica contents in the nanoparticles were 32.5% and 24.1%, respectively. CdCl 2 was purchased from Sigma Aldrich (Milan, Italy) and SiNPs from Degussa GmbH (Germany).
In vivo experiment
Adult male Sprague-Dawley rats were treated with a single intratracheal (i.t.) instillation of Cd-SiNPs (1 mg/rat, corresponding to about 250 µg Cd/rat). Separate groups of animals received i.t. an equivalent cadmium dose as CdCl 2 (400 µg/rat), SiNPs (600 µg/rat), or 0.1 ml saline/rat (control). In previous studies [14, 15] , i.t. instillation of a single dose of 400 µg CdCl 2 /rat was shown to induce in rats moderate lung injury evolving into chronic inflammation and fibrosis. Cd-SiNP suspension was vortexed on ice just before the exposure to force nanoparticle dispersion and avoid formation of agglomerates. No surfactants or solvents were used. Seven and 30 days after treatment, rats were anesthetized by i.p. injection of 35% chloral hydrate (100 µl/100 g b.w.) and kidney was carefully removed, dissected and processed for (i) histopathology (Haematoxylin/Eosin Staining) and (ii) TUNEL assay.
All experimental procedures were performed in compliance with the European Council Directive 86/609/EEC on the care and use of laboratory animals. Rats were anesthetized with pentobarbital sodium before i.t. instillation with the test materials. In addition to morphological criteria, apoptotic cell death was assayed by in situ detection of DNA fragmentation using the terminal deoxynucleotidyl-transferase (TUNEL) assay (Oncogene Res. Prod., Boston, MA, USA). The kidney sections were incubated for 5 min with 20 µg ml −1 proteinase-K solution at room temperature, followed by treatment with 3% H 2 O 2 to quench endogenous peroxidase activity. After incubation with the TUNEL solution (90 min with TdT/biotinylated dNTP and 30 min with HRP-conjugate streptavidin) in a humidified chamber at 37 °C, the reaction was developed using 0.05% 3-amino-9-ethylcarbazole (AEC) in 0.1 M TRIS buffer (pH 7.6) with 0.2% H 2 O 2 ; in some specimens the reaction was developed using a 0.1% DAB solution. The specimens were lightly counterstained with Haematoxylin. As a negative control, in some sections the TdT incubation was omitted; no staining was observed in these conditions.
The quantification of apoptotic cells was calculated as the percentage (TUNEL Labelling Index) of a total number (about 500) of TUNEL-cytochemically positive nuclei of nephron-epithelial cells (from the three kidney portion namely cortex, inner and outer medulla) for each animal and experimental condition, in a minimum of 10 randomly selected high-power microscopic fields. Statistical analyses among the different biological situations was performed by two-way analysis of variance (ANOVA) followed by the Bonferroni test.
The slides were observed and scored with a bright-field Zeiss Axioscop Plus microscope. The images were recorded with an Olympus Camedia C-2000 Z digital camera and stored on a PC running Olympus software.
Results and Discussion
Region-specific renal cell apoptosis was observed in all treatment groups, the cortex and inner medulla being the most affected regions (Figure 1 ). The apoptotic phenomena were apparent already at 7 days post-exposure in both affected areas. Notably, these effects were still observable in the inner medulla 30 days after all types of treatment, while in the cortex merely Cd-SiNPs produced a long lasting apoptotic effect. Additionally, the increase in apoptotic frequency was more pronounced in Cd-SiNPtreated animals compared to either CdCl 2 or SiNPs groups. The outer medulla was not significantly affected by any treatment. Coherently with the above reported quantitative data, Figure 2 shows representative light microscopy photomicrographs depicting significant enhancement of the apoptotic phenomenon, characterized by nuclear pyknosis, and TUNEL-positivity mainly in the cortex, both in proximal, distal tubule and glomerular region, and in the inner medulla of rats 7 days post-exposure. No evidence of necrotic tissue degeneration was detected. Histological findings demonstrated comparable morphological alterations of the renal glomerular architecture (cortex) occurring after all treatments at both time-points considered. Thirty days after (Figure 3) . Altogether, these cytohistochemical results indicate the occurrence of apoptotic phenomena and morphological changes in the renal cortex of animals i.t. instilled by all types of the test materials (CdSiNPs, CdCl 2 , SiNPs). These effects appeared early (at 7 days) and lasted until 30 days post-exposure. Notably, the kidney insult was more pronounced after Cd-SiNPs.
Our recent investigations on whole genome expression evaluated in the renal tissues after i.t. instillation of these nanoparticles, indicated that Cd-SiNPs but not CdCl 2 , induced changes in the expression of genes linked to apoptosis and regulatory processes at 30 days. The action of Cd-SiNPs was also evidenced at the earlier time point (7 days post-exposure) by modifying genes involved in immune function, stress response and inflammation processes. Similar effects were also observed 1 week post-exposure to CdCl 2 . These overall data indicate that Cd-SiNPs induced in kidney (i) longlasting gene expression changes, (ii) a more selective effect compared to CdCl 2 , (iii) delayed gene expression alterations linked to apoptosis and regulatory processes differently from CdCl 2 that did not modulate genes related to these endpoints. The approach to compare the gene expression results with biochemical and histopathological evaluation at the renal tissue may provide a direct linkage between a change in gene expression and the type and outcome of the toxic response. Both methodological approaches confirmed long-lasting renal effects of Cd-SiNPs on apoptosis and regulatory processes.
With respect to i.t. administration of bare SiNPs, we observed morphological and apoptotic changes without modification of the gene expression profile in the kidney [12] . Extra-pulmonary organ toxicity (e.g., nephrotoxicity) caused by inhaled nanoparticles have been documented in recent studies with SiNPs [5, 16] and in experiments using carbon nanotubes [17] .
The early effects caused by both Cd-SiNPs and CdCl 2 on immune, inflammation and oxidative stress processes characterized by trascriptomics still need to be specifically examined. Further investigations are in progress in our laboratories to assess renal responses to these nanomaterials applying an extended battery of assays to test more comprehensive endpoints (e.g. IL-6, TGF-beta1) comparable with those suggested by trascriptomics. These findings support the concept that multiple assays and an integrated testing strategy should be recommended to characterize toxicological responses to nanoparticles in mammalian systems.
Translocation is an important component in the toxicity of Cd which has been shown to accumulate in kidney and affect renal function after chronic inhalation exposure other than produce toxic effects on the primary target organ, i.e. lung, being the site of entry. Indeed, we observed renal gene expression changes and morphological alterations (collapsed glomeruli, showing condensed, packed mesangial and endothelial cells) not only by Cd-SiNPs but even after CdCl 2 . The total amount of Cd given to rats in this study (about 250 µg Cd/rat) was likely below the dose capable to generate critical organ concentration (100-200 µg Cd/g tissue) correlated with onset of cadmium-induced nephrotoxicity [18, 19] . In a more recent study a renal Cd level of about 8 µg/g tissue, obtained after 30 day-exposure to Cd in rat, was associated with an evident morphological changes of the renal cortex including alterations in both proximal and distal tubular cells and glomerular cells as well as in extracellular matrix [20] . Although renal Cd content in rat was not measure in the present study, we can assume that about 12 µg Cd/kidney (0.6 g) could have been reached in renal tissue of the CdCl 2 -treated animals, taking into consideration that approximately 5% of the administered Cd could be detected in rat kidney 30 days after a single i.t. instillation of 109 CdCl 2 [11] . In summary, the present results contribute to point out the involvement of a secondary organ (i.e. the kidney, a known target organ for cadmium toxicity) in the action of Cd-SiNPs given by pulmonary instillation. The renal response may be due to migration of the nanoparticles from lung to the systemic circulation or to secondary organ changes caused by circulating inflammatory factors (e.g., IL-6, IP-10 and TGF-beta1) released from lung following local insult [13] . A direct renal action of cadmium ions released from the absorbed Cd-SiNPs cannot also be excluded although a good stability of the Cddoped material used in this study was observed with no more than 15% of cadmium released from the nanoparticles dispersed in saline. Furthermore, Dynamic Light Scattering experiments with the nanoparticles dispersed in physiological solution showed agglomeration and aggregation of Cd-SiNPs to extent greater than that found with SiNPs. The more pronounced tendency of Cd-SiNPs to form aggregates and agglomerates may offer an additional mechanistic explanation of our experimental findings.
